Wall Street Analyst Picks and S&P 500 Outlook After Strong Q2

애널리스트 | Thu Jul 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) | 6 sources

Analysts highlighted First Watch, Intellia, and Revolution Medicines as notable picks while forecasting continued strength for the S&P 500 following its best quarter in six years.

Analysis

[S&P 500] posted 14% Q2 gain marking best quarterly performance in six years ^[2]

• Progress in Iran peace negotiations and falling oil prices
• Strong corporate earnings validating AI investments
• IPO expectations from tech companies including SpaceX and Anthropic

[First Watch Restaurant Group] initiated coverage with Buy rating and $17 price target from Freedom Capital ^[1]

• Analyst Lynne Collier indicated 27% upside from recent close
• Considered undervalued with PEG ratio of 0.7
• Evaluated as an emerging leader in the breakfast segment

[Intellia Therapeutics] received Wall Street average price target of $26.63 implying 57% additional upside ^[6]

• Bullish outlook maintained despite 83% year-to-date gain
• lonvo-z gene editing therapy showed 87% seizure reduction in phase 3
• nex-z for ATTR amyloidosis in phase 3 in partnership with Regeneron

[Revolution Medicines] justified $40 billion market cap without revenue through RAS(ON) pipeline ^[5]

• daraxonrasib achieved 13.2-month survival in pancreatic cancer phase 3
• RAS-related cancers account for 30% of new diagnoses
• Some analysts value the opportunity at over $10 billion

[Rivian] secured outlook for more than tripling revenue with R2 SUV launch ^[4]

• R2 starts at $57
• 990 with a $45
• 000 version planned by end of 2027
• Raised annual delivery target to 62
• 000-67
• 000 units this year
• Revenue projected to more than triple from 2025 to 2028

[Fiverr International] evaluated as successfully pivoting through AI transition by expanding high-value clients ^[3]

• 18% increase in clients with budgets over $1
• 000
• AI consulting and development category revenue more than doubled
• Undervalued at trailing P/E of 13x and 3.6x FCF

Sources

• [1] Why First Watch Restaurant Group Topped the Market Today - The Motley Fool
• [2] The S&P 500 Posted Its Best Quarterly Performance Since 2020. History Says This Happens Next. - The Motley Fool
• [3] Should You Forget Fiverr International Stock Near a 52-Week Low? - The Motley Fool
• [4] Is Rivian Stock Primed To Deliver Gains After The Launch of The R2? - The Motley Fool
• [5] Revolution Medicines Has a $40 Billion Market Cap and Generates No Revenue. Here's Why That's Not Absurd. - The Motley Fool
• [6] Wall Street Thinks This High-Flying Biotech Stock Can Soar Another 57% - The Motley Fool